Minggui Wang

221 papers receiving 8.4k citations

Minggui Wang's Hit Papers

Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial 2024 · 75 citations
750+1+2Years since publication50100150200

Peers

Minggui Wang
Comparison fields: 5 of 154
  • Molecular Medicine 4.2k
  • Applied Microbiology and Biotechnology 564
  • Endocrinology 1.2k
  • Clinical Biochemistry 595
  • Pollution 839
Replace Asad U Khan Arbab Khan with:
Asad U Khan Arbab Khan India
Didier Hocquet France
Hui Wang China
Martin Cormican Ireland
Marie-Cécile Ploy France
Bahar H. Kashef Hamadani United States
Ian Chopra United Kingdom
Oliver James Dyar Sweden
Vera Manageiro Portugal
Manivanh Vongsouvath United Kingdom
Minggui Wang relative to Asad U Khan Arbab Khan India Asad U Khan Arbab Khan's profile →
Citations per field
00.5×1.5×1.9×
Asad U Khan Arbab Khan · 1×
Citations per year

Countries citing papers authored by Minggui Wang

Since Specialization
Citations

This map shows the geographic impact of Minggui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minggui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minggui Wang more than expected).

Fields of papers citing papers by Minggui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minggui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minggui Wang. The network helps show where Minggui Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Minggui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Minggui Wang Line = papers co-authored together Minggui Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003421
2 2009284
3 2020273
4 2018270
5 2021262
6 2016243
7 2020240
8
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
Hit paper breakdown →
2023223
9 2004222
10 2008179
11 2008178
12 2010173
13 2015171
14 2019147
15 2020132
16 2016129
17 2017120
18 2009117
19 2015116
20 2017115

About Minggui Wang

Minggui Wang is a scholar working on Molecular Medicine, Endocrinology, Pharmacology, Infectious Diseases and Clinical Biochemistry, having authored 228 papers that have together received 8.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (109 papers), Antibiotics Pharmacokinetics and Efficacy (34 papers), Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (17 papers), Pneumonia and Respiratory Infections (17 papers), Advanced Photocatalysis Techniques (16 papers), Antibiotic Use and Resistance (13 papers) and Enterobacteriaceae and Cronobacter Research (13 papers). The work is most often cited by research in Molecular Medicine (4.2k citations), Applied Microbiology and Biotechnology (564 citations), Endocrinology (1.2k citations), Clinical Biochemistry (595 citations) and Pollution (839 citations). Minggui Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jie Han, Xiaogang Xu, Rong Hua Guo, Fupin Hu, David C. Hooper, Qinglan Guo, Demei Zhu, George A. Jacoby, Fu Wang and Yingyuan Zhang. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Clinical Infectious Diseases and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact